ERGO HEALTH, LLC
Ergothioneine molecule produced via fermentation-based biosynthesis
- Sector
- Biotech
- Total capital
- $225K
- Federal grants
- $225K
- 2 awards · 2019
- Rank in peer group#254 of 392
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 5 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Production Scale-Up and Target Identification of the Antioxidant Ergothioneine$8K
- Federal grantHealth and Human S · Phase I · Production Scale-Up and Target Identification of the Antioxidant Ergothioneine$217K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 392 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 5- PendingMethods For Extending The Lifespan Of Cells And OrganismsUSPTOApplication 18437501
- PendingMethod of Treating DiseasesUSPTOApplication 17904977
- PendingMethods For Extending The Lifespan Of Cells And OrganismsUSPTOApplication PCTUS2022074723
Show all 5 patent records
- Methods For Extending The Lifespan Of Cells And OrganismsNov 14, 2024 · Application 18437501Pending
- Method of Treating DiseasesApr 13, 2023 · Application 17904977Pending
- Methods For Extending The Lifespan Of Cells And OrganismsApplication PCTUS2022074723Pending
- Method Of Treating DiseasesApplication PCTUS2021019620Pending
- Method Of Treating DiseasesApplication 62981204Pending
Related companies, and why
- Design Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- CAMBRIDGE TECHNOLOGIES LLCSimilar federal contract value in Biotech · null in contracts
- MOGLING BIO INCSimilar federal contract value in Biotech · null in contracts
- South Rampart Pharma, LLCSimilar federal contract value in Biotech · null in contracts
- Twenty-Two Desserts, Inc.Similar federal contract value in Biotech · null in contracts
- AVIVA BIOSCIENCES CORPSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .